BFG
BIIB icon

Bleakley Financial Group’s Biogen BIIB Stock Holding History

Bleakley Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,608
Closed -$246K – 559
2024
Q4 		$246K Buy
1,608
+535
+50% +$90.2K 0.01% 875
2024
Q3 		$208K Sell
1,073
-759
-41% -$159K 0.01% 915
2024
Q2 		$425K Sell
1,832
-231
-11% -$50.2K 0.01% 655
2024
Q1 		$445K Sell
2,063
-228
-10% -$53.4K 0.01% 646
2023
Q4 		$593K Buy
2,291
+270
+13% +$66.3K 0.02% 541
2023
Q3 		$519K Sell
2,021
-638
-24% -$171K 0.02% 533
2023
Q2 		$757K Buy
2,659
+118
+5% +$35.1K 0.02% 476
2023
Q1 		$706K Sell
2,541
-45
-2% -$12.5K 0.02% 483
2022
Q4 		$716K Buy
+2,586
New +$730K 0.03% 453

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bleakley Financial Group's BIIB Position: Q1 2025 in Review

Bleakley Financial Group sold out of Biogen (BIIB) in Q1 2025, closing a stake of 1,608 shares — an estimated $246K sold.

Bleakley Financial Group first reported a position in BIIB in Q4 2022 and held it in 9 quarters. The position peaked at $757K in Q2 2023. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Bleakley Financial Group reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 1,608 Biogen shares in Q1 2025, an estimated $246K.
  • Bleakley Financial Group first reported a position in Biogen in Q4 2022 and held it in 9 quarters.
  • Bleakley Financial Group's Biogen position peaked at $757K in Q2 2023.
  • 883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.